100% FreeNo Signup Required

Sharpe, Sortino & Calmar Ratio Calculator

Paste a period-over-period return series — from a backtest, a live strategy, or a fund's reported monthly returns — and get all three standard risk-adjusted ratios, annualized volatility, and max drawdown in one place, with every convention (sample vs. population standard deviation, downside-deviation denominator) stated explicitly.

Return series

12 periods parsed. Paste your own strategy's or backtest's period-over-period returns.

%

Method

Sharpe = mean(excess) / stdev(excess) × √periods/yr

Sortino = mean(excess) / downside-dev × √periods/yr

Calmar = CAGR / max drawdown

Ulcer Index = √mean(drawdown²) -- Pain Index = mean(|drawdown|)

PSR = Φ[(SR−SR*)√(n−1) / √(1−skew·SR+((kurt−1)/4)SR²)]

Risk-adjusted ratios

Sharpe ratio
0.692
annualized
Sortino ratio
1.093
annualized, downside only
Calmar ratio
2.973
CAGR ÷ max drawdown
Annualized return
9.51%
Annualized volatility
7.81%
Max drawdown
-3.20%
Ulcer Index
1.22
RMS of drawdown path
Pain Index
0.64
mean of drawdown path
Probabilistic Sharpe Ratio
73.6%
confidence true Sharpe > 0

Equity curve (starting at 1.00)

Sample standard deviation (n-1) for Sharpe; downside deviation uses the full period count in its denominator, per Sortino & Price (1994) — not just the count of losing periods, which some calculators use and which inflates the ratio. A "Sharpe ratio calculator" showing a different number than this one on the same data most likely differs on exactly one of these two conventions.

The Probabilistic Sharpe Ratio (Bailey & Lopez de Prado, 2012) answers a different question than Sharpe itself: given only 12 observations and this return series' actual skewness (-0.47) and kurtosis (2.09, a normal distribution scores 0 and 3), how confident can you be that the TRUE Sharpe ratio is really above zero, rather than this track record just getting lucky? A short or fat-tailed track record can post an impressive Sharpe ratio and still score a low PSR — most free Sharpe calculators skip this entirely.

How the calculation works

Sharpe (Sharpe, 1966) divides the average excess return over the risk-free rate by the standard deviation of that excess return, then scales by the square root of the number of periods per year to annualize — the standard scaling for i.i.d. returns, since mean scales linearly with time while standard deviation scales with its square root.

Sortino (Sortino & Price, 1994) uses the same numerator but replaces total standard deviation with downside deviation: only periods where the excess return falls below the target (0, i.e. matching the risk-free rate) contribute to the sum of squares, and that sum is divided by the FULL period count — not just the count of losing periods, a distinction that materially changes the number and is a common source of disagreement between calculators.

Calmar (Young, 1991) divides the compound annual growth rate of the full entered series by its maximum drawdown — the largest peak-to-trough decline in the compounded equity curve, computed by tracking the running peak and the percentage below it at every period.

Ulcer Index and Pain Index (Martin, 1987) look at the WHOLE drawdown path instead of just its single worst point. Ulcer Index is the root-mean-square of the percentage-drawdown series — it penalizes deep AND long-lasting drawdowns more than shallow, brief ones. Pain Index is the plain average of the same series. Two strategies with identical max drawdown can score very differently here if one recovers within a month and the other stays underwater for a year.

The Probabilistic Sharpe Ratio (Bailey & Lopez de Prado, 2012) answers a different question than the Sharpe ratio itself. Sharpe says how good the risk-adjusted return looked; PSR says how confident you can be that the TRUE Sharpe ratio is actually above a benchmark (zero here), given the sample size and how non-normal the return distribution is. Skewness and kurtosis don't change the Sharpe ratio's value, but they change how much you should trust it — a short or fat-tailed track record can post an impressive Sharpe ratio and still score a low PSR, which is exactly the gap most free Sharpe calculators don't check for.

Frequently asked questions

What is a good Sharpe ratio?+

As a rough, widely-cited guide: below 1.0 is considered subpar, 1.0-2.0 is good, 2.0-3.0 is very good, and above 3.0 is excellent — but these thresholds depend heavily on the return period and asset class, and a Sharpe ratio computed from 12 monthly returns carries far less statistical confidence than one from 5 years of daily returns. Use the win rate significance calculator's logic as a mental model: a great-looking ratio from a short series is weaker evidence than a good-looking ratio from a long one.

Why is my Sortino ratio different from other calculators?+

Sortino's downside deviation formula has a real ambiguity in practice: some calculators divide the sum of squared downside deviations by the count of losing periods only, others by the total period count. This calculator uses the total period count (the convention in Sortino & Price's original 1994 paper), which produces a smaller, more conservative downside deviation than the losing-periods-only version — if another calculator shows a notably higher Sortino on the same data, this is almost always why.

Why use Sortino instead of Sharpe?+

Sharpe's standard deviation penalizes upside volatility exactly as much as downside volatility — a strategy with occasional large gains looks 'riskier' by Sharpe even though large gains are not the risk anyone actually minds. Sortino only penalizes deviations below the target (the risk-free rate here), which better matches how most people intuitively think about risk.

What does the Calmar ratio add that Sharpe and Sortino don't?+

Calmar uses maximum drawdown instead of a standard-deviation-based measure — the single worst peak-to-trough decline in the equity curve, which is what actually determines whether an investor can psychologically or financially tolerate holding a strategy through its worst period. A strategy can have a strong Sharpe ratio with volatility spread evenly across many small moves, yet still have a brutal single drawdown that Sharpe doesn't specifically flag — Calmar does.

How many return periods do I need for these ratios to mean anything?+

There's no universal cutoff, but the same statistical logic as the win rate significance calculator applies: a Sharpe ratio computed from 10-12 data points has enormous sampling uncertainty and can swing wildly with one or two outlier periods. As a practical floor, most practitioners want at least 30-36 periods (2.5-3 years of monthly data, or several months of daily data) before treating these ratios as more than a rough first look. The Probabilistic Sharpe Ratio below is this same concern turned into a number instead of a rule of thumb.

What is the Probabilistic Sharpe Ratio and why is it different from the plain Sharpe ratio?+

The Sharpe ratio is a point estimate — a single number computed from whatever return series you happened to have. The Probabilistic Sharpe Ratio (Bailey & Lopez de Prado, 2012) asks a sharper question: given the sample size and the actual skewness/kurtosis of the returns (not assuming a normal distribution), what is the probability that the TRUE, underlying Sharpe ratio is actually above a benchmark (0 by default)? A strategy with a great-looking Sharpe ratio from a short, lumpy track record can still have a low PSR — the number is telling you the good Sharpe ratio might just be luck.

What's the difference between Ulcer Index and max drawdown?+

Max drawdown only records the single worst peak-to-trough decline — a strategy that drops 20% and recovers in a week looks identical to one that drops 20% and stays there for two years. Ulcer Index (and Pain Index) look at the entire drawdown path, not just its lowest point, so a long, grinding drawdown scores worse than a sharp, brief one even at the same maximum depth — which is usually closer to what actually wears down an investor holding the strategy.

Related tools

This calculator performs arithmetic on the return series you paste in. It is not investment advice, does not evaluate any specific strategy or fund, and a strong historical ratio is not a guarantee of future performance.